Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese data

Aim It is not clear whether evaluating the clinical response to antibiotic use at day 7 among critically ill patients accurately predicts outcomes. We aimed to evaluate the relationship between clinical response to the initial empiric therapy on day 7 and mortality. Methods The determinants of antim...

Full description

Bibliographic Details
Main Authors: Chie Tanaka, Takashi Tagami, Masamune Kuno, Kyoko Unemoto, DIANA Study Japanese Group
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Acute Medicine & Surgery
Subjects:
Online Access:https://doi.org/10.1002/ams2.842
_version_ 1797374396435791872
author Chie Tanaka
Takashi Tagami
Masamune Kuno
Kyoko Unemoto
DIANA Study Japanese Group
author_facet Chie Tanaka
Takashi Tagami
Masamune Kuno
Kyoko Unemoto
DIANA Study Japanese Group
author_sort Chie Tanaka
collection DOAJ
description Aim It is not clear whether evaluating the clinical response to antibiotic use at day 7 among critically ill patients accurately predicts outcomes. We aimed to evaluate the relationship between clinical response to the initial empiric therapy on day 7 and mortality. Methods The determinants of antimicrobial use and de‐escalation in critical care (DIANA) study was an international, multicenter, observational study on antibiotic use in the intensive care unit (ICU). ICU patients ages over 18 years in whom an empiric antimicrobial regimen in Japan was initiated were included. We compared patients who were evaluated as cured or improved (“effective”) 7 days after starting antibiotic treatment with patients who were evaluated as deteriorated (“failure”). Results Overall, 217 (83%) patients were in the effective group, and 45 (17%) were in the failure group. Both the infection‐related mortality rate in the ICU and the in‐hospital infection‐related mortality rate in the effective group were lower than those in the failure group (0% versus 24.4%; P < 0.01 and 0.5% versus 28.9%; P < 0.01, respectively). Conclusion Assessment of efficacy of empiric antimicrobial treatment on day 7 may predict a favorable outcome among patients suffering from infection in the ICU.
first_indexed 2024-03-08T19:05:12Z
format Article
id doaj.art-e816ed07bcd349a5b842c18bae885f01
institution Directory Open Access Journal
issn 2052-8817
language English
last_indexed 2024-03-08T19:05:12Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series Acute Medicine & Surgery
spelling doaj.art-e816ed07bcd349a5b842c18bae885f012023-12-28T00:28:39ZengWileyAcute Medicine & Surgery2052-88172023-01-01101n/an/a10.1002/ams2.842Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese dataChie Tanaka0Takashi Tagami1Masamune Kuno2Kyoko Unemoto3DIANA Study Japanese GroupDepartment of Emergency and Critical Care Medicine Nippon Medical School Tama Nagayama Hospital Tama‐shi Tokyo JapanDepartment of Emergency and Critical Care Medicine Nippon Medical School Musashikosugi Hospital Kawasaki Kanagawa JapanDepartment of Emergency and Critical Care Medicine Nippon Medical School Tama Nagayama Hospital Tama‐shi Tokyo JapanDepartment of Emergency and Critical Care Medicine Nippon Medical School Tama Nagayama Hospital Tama‐shi Tokyo JapanAim It is not clear whether evaluating the clinical response to antibiotic use at day 7 among critically ill patients accurately predicts outcomes. We aimed to evaluate the relationship between clinical response to the initial empiric therapy on day 7 and mortality. Methods The determinants of antimicrobial use and de‐escalation in critical care (DIANA) study was an international, multicenter, observational study on antibiotic use in the intensive care unit (ICU). ICU patients ages over 18 years in whom an empiric antimicrobial regimen in Japan was initiated were included. We compared patients who were evaluated as cured or improved (“effective”) 7 days after starting antibiotic treatment with patients who were evaluated as deteriorated (“failure”). Results Overall, 217 (83%) patients were in the effective group, and 45 (17%) were in the failure group. Both the infection‐related mortality rate in the ICU and the in‐hospital infection‐related mortality rate in the effective group were lower than those in the failure group (0% versus 24.4%; P < 0.01 and 0.5% versus 28.9%; P < 0.01, respectively). Conclusion Assessment of efficacy of empiric antimicrobial treatment on day 7 may predict a favorable outcome among patients suffering from infection in the ICU.https://doi.org/10.1002/ams2.842Antibioticsclinical responseinfectionintensive care unitmortality
spellingShingle Chie Tanaka
Takashi Tagami
Masamune Kuno
Kyoko Unemoto
DIANA Study Japanese Group
Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese data
Acute Medicine & Surgery
Antibiotics
clinical response
infection
intensive care unit
mortality
title Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese data
title_full Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese data
title_fullStr Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese data
title_full_unstemmed Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese data
title_short Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub‐analysis of the DIANA study Japanese data
title_sort evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit sub analysis of the diana study japanese data
topic Antibiotics
clinical response
infection
intensive care unit
mortality
url https://doi.org/10.1002/ams2.842
work_keys_str_mv AT chietanaka evaluationofclinicalresponsetoempiricalantimicrobialtherapyonday7andmortalityintheintensivecareunitsubanalysisofthedianastudyjapanesedata
AT takashitagami evaluationofclinicalresponsetoempiricalantimicrobialtherapyonday7andmortalityintheintensivecareunitsubanalysisofthedianastudyjapanesedata
AT masamunekuno evaluationofclinicalresponsetoempiricalantimicrobialtherapyonday7andmortalityintheintensivecareunitsubanalysisofthedianastudyjapanesedata
AT kyokounemoto evaluationofclinicalresponsetoempiricalantimicrobialtherapyonday7andmortalityintheintensivecareunitsubanalysisofthedianastudyjapanesedata
AT dianastudyjapanesegroup evaluationofclinicalresponsetoempiricalantimicrobialtherapyonday7andmortalityintheintensivecareunitsubanalysisofthedianastudyjapanesedata